Healthy.io is a company.
Healthy.io has raised $123.0M across 3 funding rounds.
Key people at Healthy.io.
Healthy.io has raised $123.0M in total across 3 funding rounds.
Healthy.io has raised $123.0M in total across 3 funding rounds.
Healthy.io's investors include Aleph VC, Atooro Fund, DAG Ventures, Insight Partners, Redline Capital, Samsung NEXT Ventures.
Key people at Healthy.io.
Healthy.io is a digital health company that transforms smartphone cameras into FDA-cleared, clinical-grade medical devices for at-home diagnostics and remote monitoring.[1][2][3] It builds products like the Minuteful Kidney test, Minuteful UTI test, and Minuteful for Wound, serving patients, healthcare providers, and health plans by enabling convenient urine analysis for kidney disease, UTIs, pregnancy complications, and chronic wound tracking.[1][2][4] These solutions solve accessibility barriers in routine testing and chronic care management, offering lab-equivalent accuracy via AI, computer vision, and colorimetric analysis, while integrating seamlessly with EMRs via SMART on FHIR for 93% patient satisfaction and over 1.2 million patients engaged.[3][4]
The company democratizes healthcare by allowing tests in everyday settings, reducing clinic visits, and supporting early detection—evidenced by metrics like 1 million scans across three offices and partnerships with global systems.[3] Growth includes FDA clearance in 2018, space station deployment in 2022, and a 2024 Johns Hopkins pilot for diabetic wound care.[2][6]
Founded in 2013 by CEO Yonatan Adiri, Healthy.io emerged from a vision to leverage smartphone ubiquity for early diagnostics, starting with chronic kidney disease, UTIs, and prenatal care via urinalysis dipsticks scanned through a mobile app.[2][6] Adiri's leadership drove initial development of AI-powered computer vision to match lab accuracy despite variables like lighting.[1][2]
Pivotal moments include 2018 FDA clearance as the first Class II smartphone urinalysis device, validating equivalence to professional labs.[2] Funding milestones fueled expansion: $11.5M Series A in 2017 (Quantum Pacific), $15M in 2018, $18M Series B in 2019 (Aleph, Samsung Next), and $50M Series D by 2023 (Schusterman Family Investments, Aleph).[6] Early traction built through clinical trials, regulatory wins, and products like wound management adopted by U.S. and UK nurses by 2020.[2]
Healthy.io rides the remote diagnostics and telehealth wave, accelerated by post-pandemic demand for at-home care amid clinician shortages and rising chronic diseases like CKD (affecting millions undiagnosed) and diabetes-related wounds.[1][5][6] Timing aligns with smartphone penetration (ubiquitous calibration tools) and AI advancements in computer vision, enabling "healthcare at the speed of life" without specialized hardware.[3][4]
Market forces favor it: regulatory nods (FDA, CE) lower barriers; EMR integrations tap existing workflows; equity focus reaches underserved populations via home privacy.[3][5] It influences the ecosystem by proving smartphone viability for diagnostics, inspiring hybrid care models, and partnering with providers/health plans to cut costs, boost adherence, and enable early interventions—shifting from reactive to proactive health management.[1][7]
Healthy.io is poised to expand its platform with more AI-driven tests (e.g., beyond kidney/UTI/wounds) and holistic care tools, leveraging patents and pilots for deeper EMR embeds and global scale.[6][7] Trends like AI personalization, value-based care, and space/health extremes will shape it, potentially amplifying influence through acquisitions or pharma ties amid $60B+ digital health funding.[6]
As smartphone diagnostics mature, Healthy.io could redefine accessible care, turning "1,440 minutes in a day" into life-saving moments—building on its mission to equalize health access for all.[3]
Healthy.io has raised $123.0M across 3 funding rounds. Most recently, it raised $45.0M Series D in January 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 1, 2022 | $45.0M Series D | Aleph VC, Atooro Fund, DAG Ventures, Insight Partners | |
| Sep 1, 2019 | $60.0M Series C | Aleph VC, Atooro Fund, DAG Ventures, Insight Partners | |
| Feb 1, 2019 | $18.0M Series B | Aleph VC, Atooro Fund, DAG Ventures, Insight Partners, Redline Capital, Samsung NEXT Ventures |
